European-wide MRD screening should be available for all
All types of healthcare, including measurable residual disease (MRD) testing should be available to everyone throughout Europe. Speaking from the 2018 European School of Hematology (ESH) Clinical Upda...
Author: VJHemOnc
Added: 08/13/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Hematology